Consistent with this and our previous studies [31,73], C-terminal HSP90 inhibitors, but not N-terminal HSP90 inhibitors, altered both FN levels and cell migration in breast cancer and fibroblast lines. The gene discussed is HSP90AB1; the disease is breast carcinoma.